日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial

利用第二代分子钳技术稳定融合前构象的严重急性呼吸综合征冠状病毒2刺突蛋白亚单位疫苗在18-55岁成年人中的安全性和免疫原性:一项随机、双盲、活性对照的I期试验

Chappell, Keith J; Mordant, Francesca L; Amarilla, Alberto A; Modhiran, Naphak; Liang, Benjamin; Li, Zheyi; Lackenby, Julia A; Jaberolansar, Noushin; O'Donnell, Jake; Kienzle, Vivian; Kommajosyula, Varsha; Tardiota, Nicolas; Bennet, Jillian K; Henderson, Christina L; Dalrymple, Rhiannon L; Goh, Justin; Hoger, Kym; Gillard, Marianne; Jones, Martina L; Hughes, Karen; Hughes, Ben; Barnes, James; Reading, Patrick C; Ranasinghe, Charani; Subbarao, Kanta; Munro, Trent P; Young, Paul R; Watterson, Daniel

Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trial

一项针对18-55岁或≥56岁成年人的随机、双盲、安慰剂对照I期临床试验的12个月结果显示,MF59佐剂增强的SARS-CoV-2刺突糖蛋白钳疫苗具有长期安全性和免疫原性。

Chappell, Keith J; Mordant, Francesca L; Amarilla, Alberto A; Modhiran, Naphak; Liang, Benjamin; Li, Zheyi; Wijesundara, Danushka K; Lackenby, Julia A; Griffin, Paul; Bennet, Jillian K; Hensen, Luca; Zhang, Wuji; Nguyen, Thi H O; Tran, Mai H; Tapley, Peter; Barnes, James; Reading, Patrick C; Kedzierska, Katherine; Ranasinghe, Charani; Subbarao, Kanta; Watterson, Daniel; Young, Paul R; Munro, Trent P

Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post-vaccination but persist for at least 6 months

2018 年季节性灭活流感疫苗产生的抗体滴度在接种后 3 个月开始下降,但至少可持续 6 个月。

Mordant, Francesca L; Price, Olivia H; Rudraraju, Rajeev; Slavin, Monica A; Marshall, Caroline; Worth, Leon J; Peck, Heidi; Barr, Ian G; Sullivan, Sheena G; Subbarao, Kanta

Comparison of Seroconversion in Children and Adults With Mild COVID-19

儿童和成人轻症新冠肺炎患者血清转化率的比较

Toh, Zheng Quan; Anderson, Jeremy; Mazarakis, Nadia; Neeland, Melanie; Higgins, Rachel A; Rautenbacher, Karin; Dohle, Kate; Nguyen, Jill; Overmars, Isabella; Donato, Celeste; Sarkar, Sohinee; Clifford, Vanessa; Daley, Andrew; Nicholson, Suellen; Mordant, Francesca L; Subbarao, Kanta; Burgner, David P; Curtis, Nigel; Bines, Julie E; McNab, Sarah; Steer, Andrew C; Mulholland, Kim; Tosif, Shidan; Crawford, Nigel W; Pellicci, Daniel G; Do, Lien Anh Ha; Licciardi, Paul V

Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection

长读长RNA测序揭示SARS-CoV-2体外感染过程中宿主转录本的多聚腺苷酸化延伸和差异转录本使用情况

Chang, Jessie J-Y; Gleeson, Josie; Rawlinson, Daniel; De Paoli-Iseppi, Ricardo; Zhou, Chenxi; Mordant, Francesca L; Londrigan, Sarah L; Clark, Michael B; Subbarao, Kanta; Stinear, Timothy P; Coin, Lachlan J M; Pitt, Miranda E

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Fc工程化的ACE2-Fc是一种针对SARS-CoV-2的强效多功能制剂

Wines Bruce D, Kurtovic Liriye, Trist Halina M, Esparon Sandra, Lopez Ester, Chappin Klasina, Chan Li-Jin, Mordant Francesca L, Lee Wen Shi, Gherardin Nicholas A, Patel Sheila K, Hartley Gemma E, Pymm Phillip, Cooney James P, Beeson James G, Godfrey Dale I, Burrell Louise M, van Zelm Menno C, Wheatley Adam K, Chung Amy W, Tham Wai-Hong, Subbarao Kanta, Kent Stephen J, Hogarth P Mark

Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)

中度冠状病毒病 2019 (COVID-19) 患者呼吸道和胃肠道中可培养的严重急性呼吸道冠状病毒 2 (SARS-CoV-2) 的时间差异

Audsley, Jennifer M; Holmes, Natasha E; Mordant, Francesca L; Douros, Celia; Zufan, Sara E; Nguyen, Thi H O; Kedzierski, Lukasz; Rowntree, Louise C; Hensen, Luca; Subbarao, Kanta; Kedzierska, Katherine; Nicholson, Suellen; Sherry, Norelle; Thevarajan, Irani; Tran, Thomas; Druce, Julian

Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19

轻度至中度 COVID-19 患者对 SARS-CoV-2 的免疫反应演变

Wheatley, Adam K; Juno, Jennifer A; Wang, Jing J; Selva, Kevin J; Reynaldi, Arnold; Tan, Hyon-Xhi; Lee, Wen Shi; Wragg, Kathleen M; Kelly, Hannah G; Esterbauer, Robyn; Davis, Samantha K; Kent, Helen E; Mordant, Francesca L; Schlub, Timothy E; Gordon, David L; Khoury, David S; Subbarao, Kanta; Cromer, Deborah; Gordon, Tom P; Chung, Amy W; Davenport, Miles P; Kent, Stephen J

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques

针对SARS-CoV-2的初免-加强免疫蛋白亚单位疫苗策略在小鼠和猕猴中的免疫原性

Tan, Hyon-Xhi; Juno, Jennifer A; Lee, Wen Shi; Barber-Axthelm, Isaac; Kelly, Hannah G; Wragg, Kathleen M; Esterbauer, Robyn; Amarasena, Thakshila; Mordant, Francesca L; Subbarao, Kanta; Kent, Stephen J; Wheatley, Adam K

A point-of-care lateral flow assay for neutralising antibodies against SARS-CoV-2

一种用于检测SARS-CoV-2中和抗体的即时侧向层析检测方法

Fulford, Thomas S; Van, Huy; Gherardin, Nicholas A; Zheng, Shuning; Ciula, Marcin; Drummer, Heidi E; Redmond, Samuel; Tan, Hyon-Xhi; Boo, Irene; Center, Rob J; Li, Fan; Grimley, Samantha L; Wines, Bruce D; Nguyen, Thi H O; Mordant, Francesca L; Ellenberg, Paula; Rowntree, Louise C; Kedzierski, Lukasz; Cheng, Allen C; Doolan, Denise L; Matthews, Gail; Bond, Katherine; Hogarth, P Mark; McQuilten, Zoe; Subbarao, Kanta; Kedzierska, Katherine; Juno, Jennifer A; Wheatley, Adam K; Kent, Stephen J; Williamson, Deborah A; Purcell, Damian F J; Anderson, David A; Godfrey, Dale I